Why Novavax Stock Is Plunging Today
Copyright 1995-2022 The Motley Fool. All rights reserved.
finance
2022-06-03 15:18:56

Shares of Novavax (NVAX -20.85%) were plunging 19.3% as of 10:51 a.m. ET on Friday. The decline came after the Food and Drug Administration (FDA) released briefing documents for an advisory committee meeting scheduled for June 7. This advisory committee will review Novavax's filing for Emergency Use Authorization (EUA) of its COVID-19 vaccine NVX-CoV2373. So what
Many investors focused primarily on the following statement in the FDA briefing document: "Multiple events of myocarditis/pericarditis were reported in temporal relationship to NVX-CoV2373 administration, similar to myocarditis following mRNA COVID-19 vaccines and raising concerns for a causal relationship to NVX-CoV2373.
